 |
Recombinant adeno-associated viral vector encoding a human micro-dystrophin gene under the control of a muscle specific promoter |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | Pharma Gateway AB |
